Clinical Trial Update: Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial updating immunogenicity of a quadrivalent virus-like particle influenza vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections
• Viral Diseases

Drugs mentioned

• quadrivalent virus-like particle influenza vaccine

Snippet

Sponsor: Medicago | Conditions: Virus Diseases, RNA Virus Infections | Phase 2 | Status: COMPLETED